a silver nanocomposite , a formation method for forming the silver nanocomposite , and an application method utilizing the silver nanocomposite . the silver nanocomposite includes a silver nanoparticle conjugated to a glycosaminoglycan or glucose . the formation method includes chemically reacting silver nitrate with a reducing agent to form a silver nanoparticle conjugated to the reducing agent of a gag or glucose . the application method may include topically applying the silver nanocomposite to a wound or burn as an anti - microbial with respect to an antibiotic - resistant genotype in the wound or burn , wherein the silver nanocomposite topically applied includes the silver nanoparticle conjugated to the gag of 2 , 6 - diaminopyridinyl heparin or hyaluronan . the application method may include applying the silver nanocomposite as a coating to plastic , a catheter , or a surgical tool , wherein the silver nanocomposite applied as the coating includes the silver nanoparticle conjugated to the gag of daphp .